Tagged life-science
Press Release
TRESTLE Compliance and qordata Announce Consulting/Technology Partnership
Expert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness. Read More
Press Release
Revista to Launch the First Customized Life Science Building Database
Company will provide the bioscience real estate sector's only online archive of life science properties, as well as industry statistics and resources, national and regional market reports, and strategic networking events. Read More
Press Release
Recardio Completes Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin
Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for cardiovascular diseases, announced the completion of its Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction. Read More
Press Release
Interim Analysis of Recardio's Phase II Clinical Trial Published in European Heart Journal
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that its positive results of the interim analysis of Recardio's Phase II clinical trial in AMI were published in the latest release of the European Heart Journal. The current version of the journal relates to the presentation during the 2020 Congress of the European Society of Cardiology. Read More
Press Release
Interim Analysis of Recardio's Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that the results of the interim analysis of Recardio's Phase II clinical trial will be presented at the 2020 Congress of the European Society of Cardiology from August 29 through September 1. Read More
Press Release
Clinical Trial Outcomes of Recardio's Dutogliptin Published in the British Journal of Pharmacology
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced publication of the outcomes of the Phase 1 clinical trial of its lead candidate dutogliptin. Entitled "Safety, tolerability, pharmacokinetics, and pharmacodynamics of parenterally administered dutogliptin: A prospective dose escalating trial", the article can be accessed here: https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14208 Read More
Press Release
Keynote Speaker to Address Importance of University Technology Commercialization at Keiretsu Forum Investor Capital Expo in Philadelphia
It is as vital as ever to understand how to streamline the commercialization of technology being developed within universities and through university partnerships. At 7th Annual Keiretsu Forum Mid-Atlantic Investor Capital Expo, Keith Marmer, Executive Director, Associate Vice President for Technology & Venture Commercialization at the University of Utah, will explore this topic with attending investors. Read More
Press Release
Keiretsu Forum Mid-Atlantic Investor Academy: Telling Angel Investors the Truth and Debunking Myths About Life Science Exits
This week, Keiretsu Forum Mid-Atlantic introduces the next workshop in the Investor Academy series. The group will explore the truths and debunk the myths associated with Life Science Exits. Read More
Press Release
Keirestsu Forum Mid-Atlantic to Lead Investor Academy Workshop on What to Know Before Investing in a Startup
A term sheet is a startup company's most important marketing tool. In this workshop, Keiretsu Forum Mid-Atlantic will explore the most important elements for an investor and startup to consider when negotiating terms. Read More
Press Release
Keiretsu Forum Mid-Atlantic Portfolio Companies Go for a 'Four-Peat' at 2019 ACA Summit Innovation Showcase
Keiretsu Forum Mid-Atlantic will take four portfolio companies to the 2019 Angel Capital Association Summit. Local angels hope that one of the four companies snag "Best of Show," securing a "four-peat" for this angel investment group. Read More
Press Release
Southside Works Company, Carmell Therapeutics, to Accept Award
Carmell Therapeutics was elected as the Stephen M Goodman Most Valued Company at the 6th Annual Keiretsu Forum Mid-Atlantic and South-East Angel Capital Expo. Carmel Therapeutics will accept the award at Pittsburgh Chapter meeting on Friday. Read More
Press Release